Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
| trading_symbol | registrant_name | time | price | change | percentage_change | 
|---|---|---|---|---|---|
| CDXS | CODEXIS, INC. | 2025-10-30 17:22:01 | 2.39 | 0.03 | 1.28 | 
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDXS | 0001200375 | CODEXIS, INC. | US1920051067 | 549300KGLM6CDPTVSE20 | 710872999 | Nasdaq | 2860 | Industrial Organic Chemicals | 1231 | DE | 200 PENOBSCOT DRIVE | REDWOOD CITY | CA | 94063 | UNITED STATES | US | 650-421-8100 | 200 PENOBSCOT DRIVE, REDWOOD CITY, CA, 94063 | 200 PENOBSCOT DRIVE, REDWOOD CITY, CA, 94063 | CODEXIS INC | Protein engineering | 2002 | Stephen Dilly, Ph.D. | 165 | http://codexis.com | 152,400,000 | 90,254,000 | 90,267,464 | Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications. | 2025-10-30 15:53:22 | 
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding | 
|---|---|---|---|---|---|---|
| 2024 | 152,400,000 | 30,000,000 | 24.5098 | 82,837,311 | 12,533,672 | 17.8279 | 
| 2023 | 122,400,000 | -261,400,000 | -68.1084 | 70,303,639 | 4,356,832 | 6.6066 | 
| 2022 | 383,800,000 | -353,700,000 | -47.9593 | 65,946,807 | 786,128 | 1.2064 | 
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation | 
|---|---|---|---|---|---|---|---|---|
| Kevin Norrett | Chief Operating Officer | 2024 | 474,485 | 0 | 159,668 | 237,242 | 14,840 | 1,518,851 | 
| Alison Moore | Chief Technical Officer, Executive Vice President | 2024 | 115,382 | 0 | 248,498 | 57,691 | 71,586 | 1,102,937 | 
| Stephen Dilly | Chief Executive Officer, Director, President, Chairman Of The Board | 2024 | 713,550 | 0 | 437,446 | 535,163 | 53,800 | 3,472,920 | 
| Georgia Erbez | Chief Financial Officer | 2024 | 115,382 | 0 | 148,500 | 57,691 | 240 | 931,593 | 
| Sriram Ryali | Chief Financial Officer | 2024 | 354,202 | 0 | 159,668 | 173,812 | 163,379 | 1,483,677 | 
| Fiscal Year | Employee Count | 
|---|---|
| 2024 | 188 | 
| 2023 | 174 | 
| 2022 | 248 | 
| Fiscal Year | 2024 | 2023 | 2022 | 
|---|---|---|---|
| Revenue | 59,345,000 | 70,143,000 | 138,590,000 | 
| Cost Of Revenue | 16,288,000 | 12,809,000 | 38,033,000 | 
| Gross Profit | — | — | — | 
| Research And Development Expenses | 46,263,000 | 58,885,000 | 80,099,000 | 
| General And Administrative Expenses | 55,148,000 | 53,250,000 | 52,172,000 | 
| Operating Expenses | 117,864,000 | 138,212,000 | 173,471,000 | 
| Operating Income | -58,519,000 | -68,069,000 | -34,881,000 | 
| Net Income | -65,276,000 | -76,240,000 | -33,592,000 | 
| Earnings Per Share Basic | -0.89 | -1.12 | -0.51 | 
| Earnings Per Share Diluted | -0.89 | -1.12 | -0.51 | 
| Weighted Average Shares Outstanding Basic | 73,408,000 | 68,131,000 | 65,344,000 | 
| Weighted Average Shares Outstanding Diluted | 73,408,000 | 68,131,000 | 65,344,000 | 
| Fiscal Year | 2024 | 2023 | 2022 | 
|---|---|---|---|
| Cash And Cash Equivalents | 19,264,000 | 65,116,000 | 113,984,000 | 
| Marketable Securities Current | 54,194,000 | — | — | 
| Accounts Receivable | 4,375,000 | 10,036,000 | 31,904,000 | 
| Inventories | 1,799,000 | 2,685,000 | 2,029,000 | 
| Non Trade Receivables | — | — | — | 
| Other Assets Current | 500,000 | 600,000 | — | 
| Total Assets Current | 98,772,000 | 93,466,000 | 162,894,000 | 
| Marketable Securities Non Current | — | — | — | 
| Property Plant And Equipment | 14,197,000 | 15,487,000 | 22,614,000 | 
| Other Assets Non Current | 1,019,000 | 1,246,000 | 350,000 | 
| Total Assets Non Current | 43,098,000 | 28,624,000 | 61,877,000 | 
| Total Assets | 149,011,000 | 136,561,000 | 250,393,000 | 
| Accounts Payable | 2,838,000 | 5,947,000 | 3,246,000 | 
| Deferred Revenue | 350,000 | 3,781,000 | 13,728,000 | 
| Short Term Debt | 0 | — | — | 
| Other Liabilities Current | 6,223,000 | 4,735,000 | 15,279,000 | 
| Total Liabilities Current | 23,648,000 | 35,830,000 | 49,066,000 | 
| Long Term Debt | 28,905,000 | — | — | 
| Other Liabilities Non Current | 1,268,000 | 1,233,000 | 1,371,000 | 
| Total Liabilities Non Current | 58,436,000 | 14,116,000 | 56,530,000 | 
| Total Liabilities | 82,084,000 | 49,946,000 | 105,596,000 | 
| Common Stock | 8,000 | 7,000 | 6,000 | 
| Retained Earnings | -562,806,000 | -497,530,000 | -421,290,000 | 
| Accumulated Other Comprehensive Income | 52,000 | — | — | 
| Total Shareholders Equity | 66,927,000 | 86,615,000 | 144,797,000 | 
| Fiscal Year | 2024 | 2023 | 2022 | 
|---|---|---|---|
| Depreciation And Amortization | 4,946,000 | 5,518,000 | 5,402,000 | 
| Share Based Compensation Expense | 13,087,000 | 9,971,000 | 14,531,000 | 
| Other Non Cash Income Expense | — | — | 29,000 | 
| Change In Accounts Receivable | — | — | — | 
| Change In Inventories | -886,000 | 656,000 | 869,000 | 
| Change In Non Trade Receivables | — | — | — | 
| Change In Other Assets | — | — | — | 
| Change In Accounts Payable | -2,567,000 | 2,287,000 | 207,000 | 
| Change In Other Liabilities | — | — | 5,983,000 | 
| Cash From Operating Activities | -49,410,000 | -52,638,000 | 11,284,000 | 
| Purchases Of Marketable Securities | 90,235,000 | — | — | 
| Sales Of Marketable Securities | 1,973,000 | — | — | 
| Acquisition Of Property Plant And Equipment | 4,305,000 | 4,418,000 | 8,307,000 | 
| Acquisition Of Business | — | — | — | 
| Other Investing Activities | — | — | — | 
| Cash From Investing Activities | -56,980,000 | -4,858,000 | -13,578,000 | 
| Tax Withholding For Share Based Compensation | 0 | 404,000 | 1,488,000 | 
| Payments Of Dividends | — | — | — | 
| Issuance Of Common Stock | 31,319,000 | 8,652,000 | 0 | 
| Repurchase Of Common Stock | — | — | — | 
| Issuance Of Long Term Debt | 29,521,000 | — | — | 
| Repayment Of Long Term Debt | — | — | — | 
| Other Financing Activities | — | — | — | 
| Cash From Financing Activities | 60,522,000 | 8,167,000 | -575,000 | 
| Change In Cash | -45,868,000 | -49,329,000 | -2,869,000 | 
| Cash At End Of Period | 19,264,000 | 65,116,000 | 113,984,000 | 
| Income Taxes Paid | 17,000 | 194,000 | 100,000 | 
| Interest Paid | 2,566,000 | 44,000 | 34,000 | 
| Fiscal Year | 2024 | 2023 | 2022 | 
|---|---|---|---|
| Earnings Per Share | -0.89 | -1.12 | -0.51 | 
| Price To Earnings Ratio | -5.3596 | -2.7232 | -9.1373 | 
| Earnings Growth Rate | -20.5357 | 119.6078 | 54.5455 | 
| Price Earnings To Growth Ratio | 0.261 | -0.0228 | -0.1675 | 
| Book Value Per Share | 0.9117 | 1.2713 | 2.2159 | 
| Price To Book Ratio | 5.2319 | 2.3991 | 2.103 | 
| Ebitda | -56,813,000 | -70,528,000 | -28,090,000 | 
| Enterprise Value | 359,797,160 | — | — | 
| Dividend Yield | — | — | — | 
| Dividend Payout Ratio | — | — | — | 
| Debt To Equity Ratio | 0.4319 | — | — | 
| Capital Expenditures | 3,656,000 | -1,609,000 | 6,671,000 | 
| Free Cash Flow | -53,066,000 | -51,029,000 | 4,613,000 | 
| Return On Equity | -0.9753 | -0.8802 | -0.232 | 
| One Year Beta | 1.9877 | 2.6812 | 1.8894 | 
| Three Year Beta | 2.0583 | 2.0334 | 1.419 | 
| Five Year Beta | 1.556 | 1.5197 | 1.4092 | 
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction | 
|---|---|---|---|---|---|
| Erbez Georgia | Chief Financial Officer | 2025-10-13 | 6,239 | D | 70,636 | 
| MOORE ALISON | Chief Technical Officer | 2025-10-13 | 6,239 | D | 169,332 | 
| Opaleye Management Inc. | 10% owner | 2025-08-04 | 780 | A | 12,545,000 | 
| Opaleye Management Inc. | 10% owner | 2025-07-31 | 84,220 | A | 12,544,220 | 
| Opaleye Management Inc. | 10% owner | 2025-07-30 | 1,578 | A | 12,460,000 | 
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount | 
|---|---|---|---|---|---|---|
| Lamar Smith | 2018-05-08 | TX21 | Purchase | 2018-04-06 | — | $1,001 - $15,000 | 
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security | 
|---|---|---|---|---|
| STRS OHIO | 2025-09-30 | 241,804 | 99,100 | 2.44 | 
| AMALGAMATED BANK | 2025-09-30 | 7,000 | 2,780 | 2.518 | 
| N.E.W. Advisory Services LLC | 2025-09-30 | 793 | 325 | 2.44 | 
| NISA INVESTMENT ADVISORS, LLC | 2025-09-30 | 22,297 | 9,138 | 2.44 | 
| SG Americas Securities, LLC | 2025-09-30 | 53,000 | 21,536 | 2.461 | 
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets | 
|---|---|---|---|---|---|---|
| SEI INSTITUTIONAL INVESTMENTS TRUST | 2025-08-31 | SIIT Extended Market Index Fund - Class A | SMXAX | 13,961 | 38,113.53 | 0.0031 | 
| Northern Lights Fund Trust IV | 2025-08-31 | Inspire Small/Mid Cap ETF | ISMD | 167,280 | 456,674.4 | 0.2076 | 
| PROSHARES TRUST | 2025-08-31 | ProShares Ultra Russell2000 | UWM | 8,286 | 22,620.78 | 0.0062 | 
| PROSHARES TRUST | 2025-08-31 | ProShares Russell 2000 High Income ETF | ITWO | 1,736 | 4,739.28 | 0.0076 | 
| PROSHARES TRUST | 2025-08-31 | ProShares Hedge Replication ETF | HDG | 101 | 275.73 | 0.0011 |